These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy. Park YE; Choi YC; Bae JS; Lee CH; Kim HS; Shin JH; Kim DS J Clin Neurol; 2014 Jan; 10(1):24-31. PubMed ID: 24465259 [TBL] [Abstract][Full Text] [Related]
43. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy. F Almeida C; Bitoun M; Vainzof M FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228 [TBL] [Abstract][Full Text] [Related]
45. Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy. Liu X; Wu H; Gong J; Wang T; Yan C Mol Med Rep; 2016 May; 13(5):4273-8. PubMed ID: 27035234 [TBL] [Abstract][Full Text] [Related]
46. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630 [TBL] [Abstract][Full Text] [Related]
47. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells. James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602 [TBL] [Abstract][Full Text] [Related]
48. DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy. Abath Neto O; Martins Cde A; Carvalho M; Chadi G; Seitz KW; Oliveira AS; Reed UC; Laporte J; Zanoteli E Genet Mol Biol; 2015 May; 38(2):147-51. PubMed ID: 26273216 [TBL] [Abstract][Full Text] [Related]
49. Impaired excitation-contraction coupling in muscle fibres from the dynamin2 Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728 [TBL] [Abstract][Full Text] [Related]
56. The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy. Gal A; Inczedy-Farkas G; Pal E; Remenyi V; Bereznai B; Geller L; Szelid Z; Merkely B; Molnar MJ Clin Neuropathol; 2015; 34(2):89-95. PubMed ID: 25492887 [TBL] [Abstract][Full Text] [Related]
58. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings. Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888 [TBL] [Abstract][Full Text] [Related]
59. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies. Gineste C; Simon A; Braun M; Reiss D; Laporte J Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127 [TBL] [Abstract][Full Text] [Related]
60. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]